What is TG Therapeutics's quick ratio?

TG Therapeutics (TGTX) reported quick ratio of 5.7× in Q1 2026.

How has TG Therapeutics's quick ratio changed year-over-year?

TG Therapeutics's quick ratio increased by 86.6% year-over-year, from 3× to 5.7×.

What is the long-term trend for TG Therapeutics's quick ratio?

Over 5 years (2020 to 2025), TG Therapeutics's quick ratio has grown at a -10.6% compound annual growth rate (CAGR), from 7× to 4×.

What does quick ratio mean?

Current assets excluding inventory, divided by current liabilities at the quarter end (the 'acid-test'). A stricter liquidity measure that excludes the least-liquid current asset.

TG Therapeutics TGTX Quick ratio

Quick ratio at other companies

BiogenBIIB

3×+1.6×

BridgeBio PharmaBBIO

1.5×-3.1×

Spyre Therapeutics, Inc.SYRE

9×+0.9×

Krystal Biotech, Inc.KRYS

9.1×-0.2×

Arrowhead ResearchARWR

6.2×+1.1×

Roivant SciencesROIV

18.4×-15.1×

Other financials

Income statement

See full

Revenue$204.9M+69.6%

Gross profit$171.4M+62.8%

Operating income$34.8M+304%

Net income$19.8M+291%

EPS (diluted)$0.12+300%

Balance sheet

See full

Cash & equivalents$442.2M+235%

Total debt$753.6M+197%

Total equity$583.1M+146%

Total assets$1.5B+133%

Cash flow

See full

Operating cash flow-$17.9M+37.7%

CapEx$51.0K+104%

Free cash flow-$17.9M+37.6%

Valuation

See full

Market cap$8.15B-14.3%

Enterprise value$8.46B-11.1%

P/E17.6×-225×

P/S11.6×-13.0×

Profitability

See full

Gross margin83.1%-4.4pp

Operating margin21.3%+5.9pp

Net margin66%+55.8pp

FCF margin-6,328.4%+4,773pp

Returns & leverage

See full

Return on equity112.6%+92.9pp

Debt / equity1.3×+0.2×

Current ratio5.8×+1.8×

Where this comes from

Calculated from TG Therapeutics’s reported figures.

quick assets/total current liabilities=5.7×

Based on the most recent quarter.

The official record: TG Therapeutics’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →

Ask your AI about TG Therapeutics's quick ratio.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is TG Therapeutics's quick ratio?: TG Therapeutics (TGTX) reported quick ratio of 5.7× in Q1 2026.
How has TG Therapeutics's quick ratio changed year-over-year?: TG Therapeutics's quick ratio increased by 86.6% year-over-year, from 3× to 5.7×.
What is the long-term trend for TG Therapeutics's quick ratio?: Over 5 years (2020 to 2025), TG Therapeutics's quick ratio has grown at a -10.6% compound annual growth rate (CAGR), from 7× to 4×.
What does quick ratio mean?: Current assets excluding inventory, divided by current liabilities at the quarter end (the 'acid-test'). A stricter liquidity measure that excludes the least-liquid current asset.